Midwest Professional Planners LTD. purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,882 shares of the pharmacy operator’s stock, valued at approximately $202,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Investors Financial Group LLC boosted its holdings in Walgreens Boots Alliance by 2.7% during the 4th quarter. Investors Financial Group LLC now owns 7,092 shares of the pharmacy operator’s stock valued at $370,000 after acquiring an additional 189 shares during the period. Veriti Management LLC lifted its position in shares of Walgreens Boots Alliance by 1.5% during the fourth quarter. Veriti Management LLC now owns 13,534 shares of the pharmacy operator’s stock worth $706,000 after purchasing an additional 197 shares during the last quarter. Bangor Savings Bank boosted its stake in shares of Walgreens Boots Alliance by 0.6% during the fourth quarter. Bangor Savings Bank now owns 31,213 shares of the pharmacy operator’s stock valued at $1,628,000 after purchasing an additional 197 shares during the period. Carlton Hofferkamp & Jenks Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 1.0% in the fourth quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 19,989 shares of the pharmacy operator’s stock worth $1,019,000 after purchasing an additional 200 shares during the last quarter. Finally, Centerpoint Advisors LLC lifted its holdings in Walgreens Boots Alliance by 20.7% during the 4th quarter. Centerpoint Advisors LLC now owns 1,190 shares of the pharmacy operator’s stock valued at $62,000 after buying an additional 204 shares in the last quarter. 57.02% of the stock is owned by institutional investors.
In other news, major shareholder Walgreens Boots Alliance, Inc. sold 6,000,000 shares of the business’s stock in a transaction dated Wednesday, May 11th. The stock was sold at an average price of $150.00, for a total transaction of $900,000,000.00. Following the sale, the insider now owns 52,854,867 shares in the company, valued at $7,928,230,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 17.40% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last posted its earnings results on Thursday, March 31st. The pharmacy operator reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.20. Walgreens Boots Alliance had a net margin of 4.62% and a return on equity of 19.15%. The company had revenue of $33.76 billion during the quarter, compared to analysts’ expectations of $33.33 billion. During the same quarter in the prior year, the company posted $1.40 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.05 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 10th. Investors of record on Friday, May 20th will be paid a dividend of $0.4775 per share. The ex-dividend date is Thursday, May 19th. This represents a $1.91 annualized dividend and a yield of 4.39%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 26.34%.
A number of equities analysts have recently commented on WBA shares. Robert W. Baird lowered shares of Walgreens Boots Alliance from an “outperform” rating to a “neutral” rating and reduced their target price for the stock from $70.00 to $51.00 in a research report on Friday, April 1st. Barclays decreased their target price on Walgreens Boots Alliance from $54.00 to $50.00 and set an “equal weight” rating for the company in a research report on Friday, April 1st. UBS Group dropped their price target on Walgreens Boots Alliance from $52.00 to $49.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 5th. Royal Bank of Canada decreased their price objective on Walgreens Boots Alliance from $52.00 to $46.00 and set a “sector perform” rating for the company in a report on Friday, April 1st. Finally, Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $58.00 to $50.00 and set a “hold” rating on the stock in a report on Friday, April 1st. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $50.71.
About Walgreens Boots Alliance (Get Rating)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.